Subscribe to Newsletter

Pharma & Biopharma

Techniques & Tools Spectroscopy

What’s New in Spectroscopy?

| Markella Loi | 3 min read

We travel from the Archean era and the Italian Renaissance to the future of oral disease metabolomics with spectroscopy

Business & Education Business

Business in Brief

| Markella Loi

A roundup of this month’s business news – gene and cell therapy advancement, business partnerships and space investigation

Techniques & Tools Gas Chromatography

What’s New in Chromatography?

| Markella Loi | 3 min read

Whether you’re creating a new perfume or want to test ocean water for nuclear contaminants, chromatography has the answers

Fields & Applications Data Analysis

The Application Book 2023

| Jessica Allerton

This year’s application book summarizes recent application notes across various exciting topics

Fields & Applications Pharma & Biopharma

QTOF: Quick Off the Mark for Oligonucleotide Analysis

| Stephan Seiffert, Julia Schneider, Christian Albers, Timo Schierling | 4 min read

Experts from Axolabs GmbH and Bruker Daltonics explain the benefits behind mass spectrometry for oligonucleotides in drug discovery

Fields & Applications Pharma & Biopharma

Following My Own Path

| Markella Loi, Rich Whitworth | 7 min read

Sitting Down With… Koen Sandra, CEO and Co-owner, RIC group; Visiting Professor, Ghent University, Belgium

Techniques & Tools Liquid Chromatography

What’s New in Chromatography?

| Markella Loi | 2 min read

The latest chromatography research – from moth aphrodisiacs to vaccine biomanufacturing

Business & Education Business

Business in Brief

| Markella Loi | 2 min read

A roundup of this month’s business news – from partnerships to product launches, including a new in-line spectrometer for bioprocess control

Techniques & Tools Mass Spectrometry

The Third False Dusk of Mass Spec

| Richard van Breemen | 3 min read

Has the current era of biomedical mass spec crossed the finish line? Naysayers be warned: we’ve been here before…

Techniques & Tools Technology

Nipping Nitrosamines in the Bud

| Jonathan Angove | 5 min read

Nitrosamines are carcinogenic at low concentrations, able to form in medicines over time, and difficult to detect using conventional techniques…

Register to The Analytical Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Analytical Scientist magazine

Register